 |
0 Diseases |  |
137 Trials |
|
137 Trials |  |
5343 News |  |
| «12...79808182838485868788899091 |
- levofloxacin / Generic mfg., moxifloxacin intravenous / Generic mfg.
Enrollment change: Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients (clinicaltrials.gov) - Nov 21, 2012
P3, N=182, Terminated, Sponsor: Seoul National University Hospital
N=236 --> 182
- | New P4 trial: Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication (clinicaltrials.gov) - Nov 12, 2012
P4, N=450, Recruiting, Sponsor: National Taiwan University Hospital
- levofloxacin / Generic mfg., esomeprazole / Generic mfg.
Enrollment open: Community-based Helicobacter Pylori Eradication (clinicaltrials.gov) - Nov 11, 2012
P4, N=5000, Recruiting, Sponsor: National Taiwan University Hospital
N=236 --> 182 Completed --> Recruiting
- loperamide / Generic mfg., azithromycin / Generic mfg.
Enrollment open: Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea (clinicaltrials.gov) - Oct 31, 2012
P=N/A, N=510, Recruiting, Sponsor: Uniformed Services University of the Health Sciences
Completed --> Recruiting Not yet recruiting --> Recruiting
- | levofloxacin / Generic mfg., prulifloxacin / Generic mfg.
New P4 trial: FLOR: Comparison Between Levofloxacin and Prulifloxacin, in Internal Medicine Patients With Acute Exacerbation of COPD (clinicaltrials.gov) - Oct 17, 2012
P4, N=300, Recruiting, Sponsor: Fadoi Foundation, Italy
- levofloxacin / Generic mfg.
Trial completion: BK Treatment Study (clinicaltrials.gov) - Oct 8, 2012
P4, N=46, Completed, Sponsor: Brigham and Women's Hospital
Not yet recruiting --> Recruiting Recruiting --> Completed
- | levofloxacin / Generic mfg.
Enrollment change: Levofloxacin Pharmacokinetics (PK) in the Severely Obese (clinicaltrials.gov) - Sep 11, 2012
P4, N=15, Completed, Sponsor: University of Kentucky
Recruiting --> Completed N=25 --> 15
- | levofloxacin / Generic mfg.
New P4 trial: Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment (clinicaltrials.gov) - Aug 15, 2012
P4, N=161, Completed, Sponsor: Shanghai Jiao Tong University School of Medicine
- ||| levofloxacin / Generic mfg., moxifloxacin ophthalmic / Generic mfg.
Enrollment change: Effect on Wound Healing of Vigamox Versus Cravit (clinicaltrials.gov) - Jul 18, 2012
P4, N=79, Completed, Sponsor: Alcon Research
N=25 --> 15 N=50 --> 79
- Enrollment change: The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection (clinicaltrials.gov) - Jun 22, 2012
P4, N=134, Completed, Sponsor: National Taiwan University Hospital
N=50 --> 79 N=100 --> 134
- Trial completion: The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection (clinicaltrials.gov) - Jun 22, 2012
P4, N=134, Completed, Sponsor: National Taiwan University Hospital
N=100 --> 134 Recruiting --> Completed
- levofloxacin / Generic mfg.
Biomarker, Trial completion: Ceftidoren Versus Levofloxacin in the Treatment of Patients With Acute Exacerbations of Chronic Bronchitis (AECB) (clinicaltrials.gov) - Jun 1, 2012
P4, N=40, Completed, Sponsor: University of Milan
Recruiting --> Completed Recruiting --> Completed
- levofloxacin / Generic mfg.
Enrollment open: Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy (clinicaltrials.gov) - May 24, 2012
P4, N=440, Recruiting, Sponsor: National Taiwan University Hospital
Recruiting --> Completed Not yet recruiting --> Recruiting
- Zabolante (zabofloxacin) / Dong Wha
Trial termination: Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia (clinicaltrials.gov) - May 3, 2012
P2, N=48, Terminated, Sponsor: IASO Pharma Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Terminated; Financial considerations
- Zabolante (zabofloxacin) / Dong Wha
Enrollment change: Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia (clinicaltrials.gov) - May 3, 2012
P2, N=48, Terminated, Sponsor: IASO Pharma Inc.
Active, not recruiting --> Terminated; Financial considerations N=400 --> 48
- ||| Zemdri (plazomicin) / Ionis, Achaogen
Enrollment change: A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) (clinicaltrials.gov) - Apr 17, 2012
P2, N=145, Completed, Sponsor: Achaogen, Inc.
N=400 --> 48 N=225 --> 145
- |||| Zemdri (plazomicin) / Ionis, Achaogen
Trial completion: A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) (clinicaltrials.gov) - Apr 17, 2012
P2, N=145, Completed, Sponsor: Achaogen, Inc.
N=225 --> 145 Active, not recruiting --> Completed
- New P4 trial: Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori (clinicaltrials.gov) - Apr 9, 2012
P4, N=208, Terminated, Sponsor: Buddhist Tzu Chi General Hospital
- || levofloxacin / Generic mfg.
New P3 trial: Concomitant therapy with levofloxacyn versus sequential therapy with levofloxacin for eradication of H. pylori infection Terapia concomitante con levofloxacina verso terapia sequenziale con levofloxacina per l'eradicazione di H.pylori (EUDRACT) - Mar 19, 2012
P3, N=160, Ongoing, Sponsor: AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA' DEGLI STUDI DI NAPOLI
- levofloxacin / Generic mfg.
Trial initiation date: Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study (clinicaltrials.gov) - Feb 29, 2012
P4, N=154, Active, not recruiting, Sponsor: Ottawa Hospital Research Institute
Active, not recruiting --> Completed Initiation date: Jun 2011 --> Nov 2011
- |||||| levofloxacin / Generic mfg.
Enrollment open: Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation (clinicaltrials.gov) - Feb 28, 2012
P3, N=592, Recruiting, Sponsor: Children's Oncology Group
Initiation date: Jun 2011 --> Nov 2011 Not yet recruiting --> Recruiting
- | levofloxacin / Generic mfg., ceftaroline fosamil / Generic mfg.
Enrollment open: Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia (clinicaltrials.gov) - Feb 27, 2012
P4, N=16, Recruiting, Sponsor: Gary E. Stein, Pharm.D.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- || levofloxacin / Generic mfg.
New P3 trial: 5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection (clinicaltrials.gov) - Feb 21, 2012
P3, N=180, Completed, Sponsor: Second University of Naples
- | levofloxacin / Generic mfg.
New P4 trial: Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy (clinicaltrials.gov) - Feb 20, 2012
P4, N=440, Recruiting, Sponsor: National Taiwan University Hospital
- |||||||||| Taigexyn (nemonoxacin) / TaiGen
New P3 trial: Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP (clinicaltrials.gov) - Feb 6, 2012
P3, N=540, Completed, Sponsor: TaiGen Biotechnology Co., Ltd.
- ||||| Taigexyn (nemonoxacin) / TaiGen
New P2 trial: Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP) (clinicaltrials.gov) - Feb 4, 2012
P2, N=192, Completed, Sponsor: TaiGen Biotechnology Co., Ltd.
- | levofloxacin / Generic mfg., ceftaroline fosamil / Generic mfg.
New P4 trial: Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia (clinicaltrials.gov) - Jan 30, 2012
P4, N=16, Recruiting, Sponsor: Gary E. Stein, Pharm.D.
- Beova (vibegron) / Merck (MSD), Kissei, Kyorin, Sumitomo Pharma, Pierre Fabre
New P1 trial: A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004) (clinicaltrials.gov) - Dec 26, 2011
P1, N=4, Terminated, Sponsor: Merck Sharp & Dohme Corp.
- ciprofloxacin oral / Generic mfg., levofloxacin / Generic mfg.
Trial completion, Head-to-Head: Treatment's Duration of Acute Uncomplicated Pyelonephritis (clinicaltrials.gov) - Dec 11, 2011
P4, N=310, Completed, Sponsor: Assistance Publique - H
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- levofloxacin / Generic mfg.
Biomarker, New P4 trial: Ceftidoren Versus Levofloxacin in the Treatment of Patients With Acute Exacerbations of Chronic Bronchitis (AECB) (clinicaltrials.gov) - Nov 6, 2011
P4, N=40, Completed, Sponsor: University of Milan
- | Enbrel (etanercept) / Pfizer, Amgen
Trial completion: TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial (clinicaltrials.gov) - Oct 20, 2011
P2/3, N=81, Completed, Sponsor: Ottawa Hospital Research Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Clinical: Risk of Acute Liver Injury in Users of Antimicrobials (clinicaltrials.gov) - Sep 12, 2011
P=N/A, N=1299056, Completed, Sponsor: Bayer
- Enrollment open: Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants (clinicaltrials.gov) - Aug 30, 2011
P=N/A, N=200, Enrolling by invitation, Sponsor: Rice, James C., M.D.
Active, not recruiting --> Completed Not yet recruiting --> Enrolling by invitation
- |||| Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
Trial completion: Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (clinicaltrials.gov) - Aug 22, 2011
P2, N=132, Completed, Sponsor: Cempra Pharmaceuticals
Not yet recruiting --> Enrolling by invitation Active, not recruiting --> Completed
- ||||||| levofloxacin / Generic mfg., lansoprazole / Generic mfg., amoxicillin / Generic mfg.
Trial completion: Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori Eradication (clinicaltrials.gov) - Aug 7, 2011
P3, N=60, Completed, Sponsor: Deva Holding A.S.
Active, not recruiting --> Completed Recruiting --> Completed